PANCREAS CANCER, DUCT CELL ADENOCARCINOMA

Clinical trials for PANCREAS CANCER, DUCT CELL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new PANCREAS CANCER, DUCT CELL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for PANCREAS CANCER, DUCT CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New weapon tested in fight against tough cancers

Disease control Recruiting now

This early-stage study is testing a new type of cancer drug called MBRC-201 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe and effective dose and to see how the body processes the drug. The study will en…

Matched conditions: PANCREAS CANCER, DUCT CELL ADENOCARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

PANCREAS CANCER, DUCT CELL ADENOCARCINOMA

Get alerted when new PANCREAS CANCER, DUCT CELL ADENOCARCINOMA trials appear

New weapon tested in fight against tough cancers